Takeda Pharmaceutical Company Limited (TKPHF) Competitors & Peers
The 5 largest companies in the same industry as Takeda Pharmaceutical Company Limited, by market value — each comparable links to its own dossier. Numbers are code-computed, never estimated.
| Ticker | Relationship | Price | Comparables |
|---|---|---|---|
| JHPCY | Peer | $11.50 | P/E 32.9RSI 19Cap 76.3 B |
| GDERF | Peer | $191.38 | P/E 52.3RSI 44Cap 44.6 B |
| TAK | Peer | $18.86 | RSI 60Cap 60.2 B |
| GALDY | Peer | $39.45 | P/E 54.6RSI 49Cap 46.5 B |
| TEVJF | Peer | $38.98 | P/E 65.0RSI 88Cap 45.4 B |
How these relationships were derived
Every relationship below carries its provenance. A confirmed edge is sourced from a public filing or disclosure and links to it; an AI-inferred edge is surfaced by the relationship model and is unverified — shown for color, not as evidence.
Confirmed relationships (cited)
Sourced from a public filing or disclosure — each links to its origin.
- MRNASupplier
Own 10-K customer-concentration disclosure: TakedaPharmaceuticalCompany = 10% of revenue.
Confirmed — SEC filing / public disclosuresec.gov ↗ - NKTRSupplier
Own 10-K customer-concentration disclosure: BaxaltaIncorporatedOrTakedaPLC = 18% of revenue.
Confirmed — SEC filing / public disclosuresec.gov ↗ - MGNXSupplier
Own 10-K customer-concentration disclosure: Takeda = 17% of revenue.
Confirmed — SEC filing / public disclosuresec.gov ↗ - EXELSupplier
Own 10-Q customer-concentration disclosure: Takeda = 7% of revenue.
Confirmed — SEC filing / public disclosuresec.gov ↗
Model-inferred relationships (unverified)
Suggested by the relationship model, with no public source on file. Treat each as a lead worth checking, not as evidence.
- IQVPartner
IQVIA provides contract clinical research and trial management services (CRO).
Model-inferred, unverified — treat as a lead, not evidence - AMZNSupplier
Utilizes AWS cloud infrastructure to host genomic sequencing data and clinical trial databases.
Model-inferred, unverified — treat as a lead, not evidence - PFECompetitor
Competes in development and commercialization of therapeutics for similar indications.
Model-inferred, unverified — treat as a lead, not evidence